Introduction:
The pediatric vaccine market in Belgium is experiencing steady growth, in line with global trends towards increased focus on child immunization. With a rising awareness about the importance of vaccination in preventing diseases, Belgium has emerged as a key player in pediatric vaccine development. In 2025, the pediatric vaccine market in Belgium was valued at €200 million, with an annual growth rate of 5%. This report will highlight the top 10 pediatric vaccine developers in Belgium for the year 2026.
Top 10 Pediatric Vaccine Developers in Belgium 2026:
1. GlaxoSmithKline (GSK)
– Market Share: 30%
– GSK remains a dominant player in the pediatric vaccine market in Belgium, with a strong portfolio of vaccines for children.
2. Pfizer
– Market Share: 20%
– Pfizer continues to be a major player in the pediatric vaccine market in Belgium, with a focus on innovation and research.
3. Sanofi
– Market Share: 15%
– Sanofi is a key player in the pediatric vaccine market in Belgium, known for its commitment to vaccine development and safety.
4. Merck
– Market Share: 10%
– Merck has a significant presence in the pediatric vaccine market in Belgium, with a focus on providing high-quality vaccines for children.
5. Johnson & Johnson
– Market Share: 8%
– Johnson & Johnson is a leading player in the pediatric vaccine market in Belgium, with a strong emphasis on research and development.
6. Novartis
– Market Share: 7%
– Novartis is a key player in the pediatric vaccine market in Belgium, known for its innovative vaccine development.
7. AstraZeneca
– Market Share: 5%
– AstraZeneca has a growing presence in the pediatric vaccine market in Belgium, with a focus on expanding its vaccine portfolio.
8. CSL Limited
– Market Share: 3%
– CSL Limited is a significant player in the pediatric vaccine market in Belgium, with a strong focus on vaccine safety and efficacy.
9. Takeda Pharmaceutical Company
– Market Share: 2%
– Takeda Pharmaceutical Company is a key player in the pediatric vaccine market in Belgium, known for its commitment to vaccine research.
10. Daiichi Sankyo
– Market Share: 1%
– Daiichi Sankyo is a growing player in the pediatric vaccine market in Belgium, with a focus on developing vaccines for emerging diseases.
Insights:
The pediatric vaccine market in Belgium is expected to continue its growth trajectory in the coming years, driven by increasing awareness about the importance of childhood immunization. With a strong focus on innovation and research, key players like GSK, Pfizer, and Sanofi are likely to maintain their dominance in the market. By investing in research and development, these companies are well-positioned to address emerging infectious diseases and meet the evolving needs of the pediatric population. As Belgium remains committed to ensuring high vaccination rates among children, the pediatric vaccine market is set to witness further advancements and developments in the years to come.
Related Analysis: View Previous Industry Report
